Hi dready,
I guess that you haven't been trading the share market for very long.
The shares are worth what the market is willing to pay for them - not what you think they're worth. I might think BTA is worth $50million per share, but the market disagrees.
What PE is the market willing to pay for a Biotech royalty company? I guess you'll have to ask the institutional funds who are creating biotech royalty funds. You'd know about that already right?
Joel
- Forums
- ASX - By Stock
- abn amro moves to buy
Hi dready,I guess that you haven't been trading the share market...
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)